Nexus Surgical & Med
Ticker > Company >

Nexus Surgical & Med share price

Nexus Surgical And Medicare Ltd.

BSE: 538874 SECTOR: Finance - Stock Broking  22.61 K   31   0

21.37
+1.63 (8.26%)
BSE: 05 Sep 04:02 PM

Price Summary

Today's High

₹ 22

Today's Low

₹ 19.74

52 Week High

₹ 29.28

52 Week Low

₹ 13.8

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 11.69 Cr.

Advances

₹ 0 Cr.

No. of Shares

0.55 Cr.

P/E

20.84

P/B

9.61

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  2.22

Operating Revenue

₹ 3.47 Cr.

Net Profit

₹ 0.21 Cr.

Promoter Holding

18.73 %

EPS (TTM)

₹  1.03

Sales Growth

123.68

ROE

46.41 %

ROCE

64.47%

Profit Growth

24.96 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Income Growth

1 Year123.68%
3 Year-2.46%
5 Year10.19%

Profit Growth

1 Year24.96%
3 Year11.47%
5 Year31.38%

ROE%

1 Year46.41%
3 Year297.2%
5 Year133.93%

ROCE %

1 Year64.47%
3 Year399.51%
5 Year197.75%

ROA%

15.775

PEG Ratio

0.84

PAT Margin (%)

6.1397

EPS Growth(%)

24.9494

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 18.73 0.00
Mar 2025 18.73 0.00
Dec 2024 18.73 0.00
Sep 2024 18.73 0.00
Jun 2024 18.73 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has maintained a good ROA of 15.8166946340821% in last 3 years.
  • Company has a healthy Return on Equity (ROE) track record of 297.199710963856%.
  • TThe company has been maintaining a healthy ROCE of 399.510397557353% since last 3 years.

 Limitations

  • Promoters shareholding is low at 18.73%.
  • The company is trading at 9.60665318049 times the book value.
  • The company has delivered poor profit growth of -2.46395211579876% over past 3 years
  • The company has delivered poor Operating Income growth of -2.46395211579876% over past 3 years.
  • Provision and contingencies have increased by 4618.64598025388%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Operating Revenue 1.76 1 1.48 1.48 1.73
Other Income 0 0 0 0.01 0
Interest Expended 0 0 0 0 0
Operating Expenses 1.64 0.72 1.33 1.37 1.52
Total Provisions 0 0 0 0 0
Depreciation 0 0 0 0 0
Profit Before Tax 0.12 0.28 0.15 0.12 0.2
Tax 0.03 0.07 0.04 0.03 0.05
Net Profit 0.09 0.21 0.11 0.09 0.15
Adjusted EPS (RS) 0.16 0.38 0.21 0.16 0.28

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Operating Income 1.73 3.74 2.4 1.55 3.47
Other Income 0 0.01 0.02 0.01 0.03
Interest 0 0 0 0 0.01
Operating Expenses 1.62 3.58 2.03 1.34 3.18
Total Provisions 0.04 0 0 0 0.02
Exceptional Items -5.35 0 0 0 0
Profit Before Tax -5.28 0.17 0.39 0.23 0.29
Tax 0.02 0.02 0.1 0.06 0.08
Profit After Tax -5.3 0.15 0.29 0.17 0.21
Adjusted EPS (Rs.) -9.68 0.28 0.53 0.31 0.39

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 5.47 5.47 5.47 5.47 5.47
Total Reserves -5.73 -5.58 -5.29 -5.12 -4.91
Borrowings 0 0 0 0 0
Other N/C liabilities -0.01 -0.01 -0.01 -0.01 -0.01
Current liabilities 0.47 1.04 1.82 0.56 1.24
Total Liabilities 0.2 0.92 1.99 0.91 1.8
Assets
Loans 0 0 0 0 0
Net Block 0.02 0.02 0.01 0.02 0.02
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Other Loans 0.04 0.09 0.18 0 0.03
Other N/C Assets 0 0 0 0 0
Current Assets 0.14 0.81 1.8 0.88 1.75
Total Assets 0.2 0.92 1.99 0.91 1.8
* Other Non-current Liabilities include Net deferred Liabilities

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 18.73 18.73 18.73 18.73 18.73
mildred mercantile privat... 18.55 18.55 18.55 18.55 18.55
ramasubramanian p 0.09 0.09 0.09 0.09 0.09
venkatramani n 0.09 0.09 0.09 0.09 0.09
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 81.27 81.27 81.27 81.27 81.27
a & a capital services pv... 2.64 2.64 2.64 2.64 2.64
acquitor financial servic... 1.49 1.49 - 2.16 2.22
alpana sharma 1.83 1.83 1.83 1.83 1.83
ashok kumar dugar 1.46 1.46 1.46 1.46 1.46
bhanabhai g parmar 3.51 3.51 3.51 3.51 3.51
desh raj singha 1.83 1.83 1.83 1.83 1.83
globe capital market limi... 2.38 2.38 2.38 2.38 2.38
harivardhan steel & alloy... 14.30 14.78 16.01 16.01 16.07
kawaljeet singh duggal 1.83 1.83 1.83 1.83 1.83
khattu constructions and ... 4.79 4.79 4.79 4.79 4.79
laxman sopan waghmode - - - 1.02 1.02
nishu finlease private li... 1.10 1.10 1.10 1.10 1.10
rajendrabhai bhanushankar... 1.83 1.83 1.83 1.83 1.83
ritika chona 1.83 1.83 1.83 1.83 1.83
ruchee chotra 1.46 1.46 1.46 1.46 1.46
shyam alcohol and chemica... 6.27 6.27 6.27 5.00 5.00
yadvendra sharma 2.49 2.49 2.49 2.49 2.49
rajeev kumar singh 1.83 1.83 1.83 - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Nexus Surgical & Med Stock Price Analysis and Quick Research Report. Is Nexus Surgical & Med an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Nexus Surgical & Med. 

Key Financials -

  • Profitability: Profit margin (PAT margin) of the company shows how well a company controls its cost. It is one of the important indicators to show the financial health of the company. Net profit of Nexus Surgical & Med is Rs 0.2133085 Cr. and the compounded growth of profit in the past 3 years is 11.4710286178471%. The PAT margin of Nexus Surgical & Med is 6.1397%.
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Nexus Surgical & Med , the EPS grew by 24.9359% YOY. 

 Financial Ratios -

  • Return on Equity (ROE): Nexus Surgical & Med has a healthy ROE track record. The ROE of Nexus Surgical & Med is at 46.4121% for the latest year.
  • P/E Ratio: Relative valuation metrics like the P/E ratio can be used to see if the stock of Nexus Surgical & Med is worth at the current levels at Rs 21.37. Nexus Surgical & Med is trading at a current P/E ratio of 34.5818 and the average historical P/E for the last 5 years was 17.7569389787733.
  • P/B ratio can be one of the best metrics to value such companies. Currently, Nexus Surgical & Med is trading at a P/B of 9.60665318049. The average historical P/B for the last 5 years was 0.928920057117961. This can be compared with the Market price per share in order to know if the stock is undervalued or overvalued.

One can find all the Financial Ratios of Nexus Surgical & Med in Ticker for free. Also, one can get the intrinsic value of Nexus Surgical & Med by using Valuation Calculators, which are available with a Finology ONE subscription. 

Nexus Surgical & Med FAQs

Q1. What is Nexus Surgical & Med share price today?
Ans: The current share price of Nexus Surgical & Med is Rs 21.37.

Q2. What is the market capitalisation of Nexus Surgical & Med?
Ans: Nexus Surgical & Med has a market capitalisation of Rs 11.6934503 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Nexus Surgical & Med?
Ans: The PE ratio of Nexus Surgical & Med is 20.8447132266875 and the P/B ratio of Nexus Surgical & Med is 9.60665318049, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Nexus Surgical & Med share?
Ans: The 52-week high share price of Nexus Surgical & Med is Rs 29.28, and the 52-week low share price of Nexus Surgical & Med is Rs 13.8.

Q5. Does Nexus Surgical & Med pay dividends?
Ans: Currently, Nexus Surgical & Med does not pay dividends. Dividend yield of Nexus Surgical & Med is around 0%.

Q6. What are the face value and book value of Nexus Surgical & Med shares?
Ans: The face value of Nexus Surgical & Med shares is Rs 10, while the book value per share of Nexus Surgical & Med is around Rs 2.2245. Face value is the nominal value set by the company, whereas book value reflects its accounting worth. 

Q7. What are the ROE and ROCE of Nexus Surgical & Med?
Ans: The ROE of Nexus Surgical & Med is 46.4121% and ROCE of Nexus Surgical & Med is 64.4699%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q8. Is Nexus Surgical & Med a good buy for the long term?
Ans: The Nexus Surgical & Med long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q9. Is Nexus Surgical & Med undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Nexus Surgical & Med appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q10. How to check Nexus Surgical & Med’s financials?
Ans: You can review Nexus Surgical & Med’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Nexus Surgical & Med
X